Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PFE

Pfizer Inc

Jun 18 • 04:00PM ET

25.21

-0.71 -2.74 %

Healthcare • Drug Manufacturers - General • USA • Large • NYSE

Jun 18, 4:15 PMPfizer reaffirms 2026 outlook for $59.5–$62.5 billion revenue and $2.80–$3.00 adjusted EPS in today's SEC filing

Peers: MRK LLY JNJ ABBV AZN BMY NVS AMGN SNY GSK

| Held by: VTI VOO IVV SPY VTV XLV HDV VYM DVY FDL

Index	S&P 500	P/E	19.33	EPS (ttm)	1.30	Insider Own	0.11%	Shs Outstand	5.70B	Perf Week	-3.67%
Market Cap	143.68B	Forward P/E	8.93	EPS next Y	2.82	Insider Trans	-0.03%	Shs Float	5.69B	Perf Month	-1.75%
Enterprise Value	195.37B	PEG	-	EPS next Q	0.68	Inst Own	69.66%	Short Float	2.86%	Perf Quarter	-8.03%
Income	7.46B	P/S	2.27	EPS this Y	-8.12%	Inst Trans	1.29%	Short Ratio	4.50	Perf Half Y	-1.25%
Sales	63.31B	P/B	1.59	EPS next Y	-4.55%	ROA	3.60%	Short Interest	162.66M	Perf YTD	1.24%
Book/sh	15.81	P/C	10.99	EPS next 5Y	-8.95%	ROE	8.29%	52W High	28.75 -12.30%	Perf Year	5.57%
Cash/sh	2.29	P/FCF	15.15	EPS past 3/5Y	-37.19% -3.57%	ROIC	4.95%	52W Low	23.11 9.09%	Perf 3Y	-37.07%
Dividend Est.	1.75 (6.96%)	EV/EBITDA	8.23	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	65.16%	Volatility	1.87% 1.68%	Perf 5Y	-35.04%
Dividend TTM	1.72 (6.82%)	EV/Sales	3.09	EPS Y/Y TTM	-5.39%	Oper. Margin	27.08%	ATR (14)	0.52	Perf 10Y	-22.26%
Dividend Ex-Date	May 08, 2026	Quick Ratio	0.94	Sales Y/Y TTM	1.36%	Profit Margin	11.79%	RSI (14)	38.70	Recom	2.48
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.25	EPS Q/Q	-9.78%	SMA20	-2.47%	Beta	0.29	Target Price	28.92
Payout	126.85%	Debt/Eq	0.72	Sales Q/Q	5.37%	SMA50	-3.95%	Rel Volume	3.30	Prev Close	25.92
Employees	75000	LT Debt/Eq	0.67	Earnings	May 05 BMO	SMA200	-2.58%	Avg Volume	36.15M	Price	25.21
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.92% 4.41%	Trades		Volume	119,385,687	Change	-2.74%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-10-26	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$25
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41

Show Previous Ratings

Jun-18-26 08:56PM	How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story (Trefis)
04:57PM	What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine? (Trefis)
03:16PM	PFE Stock Drops 3% On Surprise CFO Exit Despite Reaffirmed 2026 Guidance (Stocktwits)
01:59PM	Pfizer Shares Dip 1.5% as CFO Dave Denton Announces Exit (GuruFocus.com)
01:59PM	Pfizer CFO Exit Adds Pressure (GuruFocus.com)
12:01PM	Loading…
12:01PM	Why Accenture, Pfizer, and Kroger are moving today (Yahoo Finance Video)
10:34AM	VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026 (Exec Edge)
08:59AM	Pfizer Shares Slip Following CFO Transition Announcement (InvestorsHub)
08:40AM	Pfizer's CFO is stepping down to take a job in consumer goods (Quartz)
08:30AM	Pfizer CFO Dave Denton stepping down in August 2026 (Quartz)
08:22AM	FreeCast surges premarket; Accenture, Novocure slide (Investing.com)
06:55AM	Pfizer CFO to step down; Denali sells a regulatory fast-pass (BioPharma Dive)
06:45AM	Pfizer Announces Chief Financial Officer Transition (Business Wire)
Jun-17-26 02:21PM	Eli Lilly Stock's Trillion-Dollar Question (Trefis)
01:08PM	The Number That Could Test Johnson & Johnson Stock (Trefis)
11:57AM	Loading…
11:57AM	Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished (Trefis)
08:00AM	Big pharma taps UK playbook to pressure Europe on drug prices (Reuters Videos)
Jun-16-26 02:52PM	Novo Nordisk to File Oral Wegovy in China (GuruFocus.com)
08:37AM	Novo Seeks China Approval for Wegovy Pill (GuruFocus.com)
Jun-15-26 07:06AM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
Jun-12-26 04:53PM	What Could Push JNJ Stock Higher From Here? (Trefis)
03:14PM	JNJ Raised the Bar: So Why Is the Stock Standing Still? (Trefis)
01:31PM	The Catch Hiding In Eli Lilly Stock's Growth Story (Trefis)
Jun-11-26 02:03PM	Why Did Wall Street Misprice JNJ Stock? (Trefis)
08:00AM	Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub (TMX Newsfile)
Jun-10-26 03:55PM	Veteran Analyst Revamps Pfizer Stock Price Target for Rest of 2026 (GuruFocus.com)
03:47PM	Pfizer upgraded by RBC as valuation resets ahead of key pipeline catalysts (Investing.com)
Jun-09-26 10:10AM	GSK Buys Nuvalent for $10.6 Billion in Major Cancer Push (Bloomberg)
06:13AM	Pfizer's Hympavzi secures FDA expanded indications for haemophilia (Pharmaceutical Business Review)
05:18AM	Will obesity drugs save Pfizer from its post-COVID slump? (Pharma Voice)
04:07PM	Loading…
Jun-08-26 04:07PM	Sciwind Reports 12.8% Weight Loss As Global Expansion Talks Deepen (GuruFocus.com)
03:49PM	Why Is Lilly Stock Growing Like A Silicon Valley Tech Darling? (Trefis)
10:30AM	Pfizer's monthly weight loss shot posted side effects similar to Wegovy in mid-stage trial (Quartz)
09:07AM	Can MariTide Save Amgen Stock From Its Fading Blockbusters? (Trefis)
08:55AM	Is AbbVie Stock The Right Defensive Pick In This Volatile Market? (Trefis)
07:01AM	ADA 26: Lillys dominance, Pfizers foundational drug and Roches me-too option (BioPharma Dive)
06:45AM	U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need (Business Wire)
04:58AM	3 potential takeover targets in obesity (Pharma Voice)
Jun-06-26 02:53PM	Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy. (MarketWatch)
10:04AM	Pfizer targets obesity market with monthly weight-loss injection data (Investing.com)
09:00AM	Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide (Business Wire)
Jun-05-26 06:55PM	Is Amgen An Undervalued Stock Or Value Trap? (Trefis)
09:41AM	Pfizer licenses Chai Discovery AI platform for drug discovery (Quartz)
06:05AM	Pfizer signs licence agreement with Chai for AI drug discovery (Pharmaceutical Business Review)
Jun-04-26 04:23PM	75% Upside For LLY Stock? (Trefis)
Jun-03-26 10:37AM	US lawmakers reveal policy to curb collaboration with Chinese biotech (Pharmaceutical Technology)
Jun-01-26 10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
12:25AM	SMMT Stock Surges Overnight: Cancer Drug Survival Win Raises The Bar As PFE, BMY, MRK Chase Keytruda's Successor (Stocktwits)
May-31-26 05:02PM	Could GLP-1 drugs become oncologys next big opportunity? (Investing.com)
08:02AM	How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers (Investor's Business Daily)
08:00AM	Growing US reliance on Chinese biotechs prompts national security fears (Financial Times)
08:00AM	Pfizers BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer (Business Wire)
May-30-26 08:00AM	TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer (Business Wire)
May-29-26 02:40PM	Pfizer's $10.5 Billion Oncology Bet Sends Innovent Shares Surging (GuruFocus.com)
09:45AM	Pfizer Expands Oncology Pipeline in $10.5B Innovent Deal (GuruFocus.com)
08:00AM	Seven-Year Analysis from Pfizers LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer (Business Wire)
07:37AM	Pfizer and Innovent Biologics sign $10.5B cancer drug deal (Quartz)
06:07AM	Pfizer and Innovent Biologics sign $10.5bn cancer drug development deal (Pharmaceutical Technology)
04:54AM	Can AI crack pharmas drug repurposing goldmine? (Pharma Voice)
03:14AM	Pfizer, Innovent strike $10B cancer drug deal (BioPharma Dive)
May-28-26 07:00PM	Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines (Business Wire)
May-27-26 11:07AM	This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative. (Barrons.com)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
May-26-26 12:42PM	Thinning revenues: inside the $14bn Eliquis patent cliff (Pharmaceutical Technology)
May-25-26 07:00AM	Pfizer's CEO uses AI to make his biggest calls and 64% of CEOs agree, quietly shifting your portfolio (Moneywise)
May-22-26 09:23PM	Fed Hawks Now Rule. Will Warsh Go Along with Them? (Barrons.com)
12:47PM	Scott Melker explains why the Fed was secretly designed for banks (Yahoo Finance Video)
10:23AM	Merck Stock Climbs on Cancer Data. Why the Drugmaker Is More Than a One-Trick Pony. (Barrons.com)
May-20-26 02:14PM	Pfizer Advances Pneumonia Vaccine After 15-Fold Antibody Response Data (GuruFocus.com)
07:33AM	Value Stocks With Earnings Strength Post 3,500% Run Since 2000 (Bloomberg)
06:43AM	Immunovants potential autoimmune blockbuster; Waves RNA editing update (BioPharma Dive)
05:08AM	How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise (Investor's Business Daily)
05:05AM	Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results (Business Wire)
May-14-26 08:34PM	Pfizer receives EC approval for Hympavzi to treat haemophilia (Pharmaceutical Business Review)
02:22PM	Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch (Barrons.com)
May-13-26 08:34PM	Protalix BioTherapeutics, Inc. Q1 2026 Earnings Call Summary (Moby)
06:45AM	European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors (Business Wire)
May-12-26 08:05AM	Arvinas, Pfizer find new partner for Protac breast cancer drug (BioPharma Dive)
07:39AM	BridgeBios Attruby challenges Pfizers Vyndamax legacy in pivotal ATTR trial (Pharmaceutical Technology)
05:11AM	How tough is it getting for vaccine makers in the U.S.? (Pharma Voice)
May-08-26 01:50PM	Nasdaq, S&P 500 Enjoy Another Record-Breaking Week (Schaeffer's Research)
11:42AM	GLP-1 battle heats up between Eli Lilly and Novo Nordisk (Yahoo Finance Video)
May-06-26 02:06PM	Pfizer CEO Backs Trump's CDC Pick After Vaccine Policy Upheaval (GuruFocus.com)
09:15AM	Can Pfizer Stock Outrun A $17B Revenue Void? (Trefis)
03:00AM	CellCentric raises $220M for a transformative multiple myeloma medicine (BioPharma Dive)
May-05-26 04:54PM	Pfizer Inc. Q1 2026 Earnings Call Summary (Moby)
03:56PM	Pfizer CEO Says Digging Out of Post-Covid Hole Will Take a Few More Years (The Wall Street Journal)
02:41PM	Pfizer Beats Sales Estimates As $17 Billion Patent Cliff Looms (GuruFocus.com)
01:30PM	Pfizer pins post 2028 return to growth on new obesity and cancer drugs (Reuters)
12:41PM	Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidance (Proactive)
12:30PM	Chicken or the Egg? Why We Need to Rethink Data and Funding in Startups (Entrepreneur)
11:05AM	Pfizer tops Q1 expectations on growth from newer products (InvestorsHub)
10:44AM	2 Trendlines in Focus For Pfizer Stock After Earnings (Schaeffer's Research)
09:54AM	BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. (Barrons.com)
09:02AM	Stock Futures Higher on Cooling Oil, Upbeat Earnings (Schaeffer's Research)
08:53AM	Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics (Investor's Business Daily)
08:45AM	Pfizer Q1 2026 earnings beat estimates on newer drug growth (Quartz)
08:35AM	Pfizer Posts Better-Than-Expected Revenue, Profit (The Wall Street Journal)
08:00AM	How Pfizers CEO says he uses AI to make decisions (CNN Business)
07:34AM	Pfizer beats first quarter estimates on strong product growth (Investing.com)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Ph.D.Dr. Albert Bourla D.V.M.

Executive VP & CFOMr. David M. Denton

M.D.Dr. Chris Boshoff FMedSci

Executive VP & Chief Legal OfficerMr. Douglas M. Lankler

Executive VP & Chief U.S. Commercial OfficerMr. Aamir Malik

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Jun 09 '26	Sale	25.70	2,000	51,400	31,397	Jun 10 07:58 PM
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM

Open in Screener

KMX

Carmax Inc

Jun 18 • 04:00PM ET

53.66

+6.23 13.14 %

Consumer Cyclical • Auto & Truck Dealerships • USA • Mid • NYSE

Peers: AN CARG LAD GPI CVNA PAG SAH LKQ AAP AZO

| Held by: IJR VTI VB AVUV CALF VBR VXF IJS SPSM RWJ

Index	-	P/E	35.32	EPS (ttm)	1.52	Insider Own	3.51%	Shs Outstand	141.91M	Perf Week	4.05%
Market Cap	7.61B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	136.79M	Perf Month	47.95%
Enterprise Value	25.53B	PEG	-	EPS next Q	0.69	Inst Own	108.26%	Short Float	11.06%	Perf Quarter	26.62%
Income	222.54M	P/S	0.27	EPS this Y	-12.70%	Inst Trans	2.13%	Short Ratio	4.37	Perf Half Y	32.07%
Sales	27.73B	P/B	1.24	EPS next Y	-	ROA	0.82%	Short Interest	15.13M	Perf YTD	38.87%
Book/sh	43.12	P/C	10.46	EPS next 5Y	-0.61%	ROE	3.59%	52W High	71.99 -25.46%	Perf Year	-16.59%
Cash/sh	5.13	P/FCF	7.65	EPS past 3/5Y	-17.96% -18.02%	ROIC	0.92%	52W Low	30.26 77.33%	Perf 3Y	-32.61%
Dividend Est.	-	EV/EBITDA	37.46	Sales past 3/5Y	-3.76% 6.67%	Gross Margin	10.37%	Volatility	6.16% 5.40%	Perf 5Y	-52.58%
Dividend TTM	-	EV/Sales	0.92	EPS Y/Y TTM	-58.01%	Oper. Margin	1.11%	ATR (14)	2.59	Perf 10Y	7.06%
Dividend Ex-Date	-	Quick Ratio	0.82	Sales Y/Y TTM	-3.30%	Profit Margin	0.80%	RSI (14)	68.81	Recom	3.10
Dividend Gr. 3/5Y	- -	Current Ratio	2.70	EPS Q/Q	-5.27%	SMA20	15.15%	Beta	1.17	Target Price	45.58
Payout	0.00%	Debt/Eq	3.05	Sales Q/Q	-0.23%	SMA50	26.58%	Rel Volume	2.11	Prev Close	47.43
Employees	27796	LT Debt/Eq	2.94	Earnings	Jun 17 BMO	SMA200	23.39%	Avg Volume	3.47M	Price	53.66
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	35.71% 7.94%	Trades		Volume	7,330,270	Change	13.14%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-18-26	Upgrade	Stephens	Equal-Weight → Overweight	$66
May-27-26	Initiated	UBS	Neutral	$42
Apr-15-26	Resumed	BofA Securities	Underperform	$40
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90

Show Previous Ratings

Jun-18-26 06:54PM	The Price Of A CarMax Sales Beat (Trefis) +13.14%
01:29PM	KMX Stock Recoups Earnings Day Losses Analysts Pour Praise On New CarMax CEOs Focus On Cost And Customer Experience (Stocktwits)
09:02AM	CarMax Q1 FY2027 earnings beat: Keith Barr unveils growth strategy (Quartz)
09:02AM	CarMax beat earnings estimates but is facing falling used-car margins as new CEO unveils growth strategy (Quartz)
Jun-17-26 03:01PM	KMX Stock Slides Nearly 9% CarMax CEO Flags Operational Challenges, Says Costs Are Too High (Stocktwits) -8.98%
03:00PM	Loading…
03:00PM	CarMax Inc (KMX) Q1 2027 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ... (GuruFocus.com)
11:09AM	?? Under the Radar: CarMax Stock Slides as CEO Flags Challenges (The Wall Street Journal)
10:34AM	CarMax shares drop as margin pressure overshadows strong quarterly results (Proactive)
10:12AM	Options Traders Circle CarMax Stock After Post-Earnings Pivot (Schaeffer's Research)
08:45AM	CarMax Tops Expectations as Growth Plan Gains Momentum (KMX) (InvestorsHub)
06:48AM	CarMax beats estimates as new strategy drives early results (Investing.com)
06:38AM	CarMax Profit Falls Despite Higher Sales (The Wall Street Journal)
06:37AM	CarMax Stock Rises. Used-Car Retailer Tops Earnings Estimates. (Barrons.com)
06:05AM	CarMax: Fiscal Q1 Earnings Snapshot (Associated Press)
05:50AM	CarMax Reports First Quarter Fiscal 2027 Results (Business Wire)
02:00PM	Loading…
Jun-14-26 02:00PM	The FOMC Meeting, Retail Sales Data, Kroger Earnings, and More to Watch This Week (Barrons.com)
May-28-26 05:00PM	CarMax Announces First Quarter Conference Call and Annual Meeting Information (Business Wire)
May-27-26 09:35AM	FedEx upgraded, Dollar General downgraded: Wall Street's top analyst calls (The Fly)
May-12-26 04:40PM	CarMax Announces Robert O'Shaughnessy to Join Board of Directors (Business Wire)
May-08-26 10:43AM	Will Carvana Continue To Rally Post Stock Split? (Trefis)
Apr-17-26 08:13AM	CarMax prices start to fall as turnaround plan begins (Wards Auto)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	CarMax cut its prices to bring back buyers. It just reported a $121 million loss (Moneywise)
03:01AM	CarMax Inc (KMX) Q4 2026 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
Apr-14-26 04:46PM	CarMax, Inc. Q4 2026 Earnings Call Summary (Moby) -15.12%
02:10PM	Tesla stock upgraded, CarMax Q4 earnings disappoint Wall Street (Yahoo Finance Video)
01:23PM	Why CarMax Stock Is Sinking Despite Earnings Beat (Investor's Business Daily)
12:44PM	CarMax Shares Drop 12% As Profit Per Vehicle Set To Decline (GuruFocus.com)
11:11AM	CarMax Drops as Investors Underwhelmed by Revival Strategy (Bloomberg)
07:32AM	CarMax beats FQ4 forecasts, flags $141mn goodwill charge; shares dip (Investing.com)
07:23AM	Loading…
07:23AM	CarMax Swings to Loss After Cutting Prices to Bring Back Shoppers (The Wall Street Journal)
07:09AM	CarMax: Fiscal Q4 Earnings Snapshot (Associated Press)
07:04AM	CarMax Stock Sinks After Earnings. New CEO Has Work to Do. (Barrons.com)
06:50AM	CarMax Reports Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
06:00AM	Morning Brief: Goldman rakes it in, but issues a warning (Yahoo Finance)
04:57AM	JPMorgan, Citi and Wells Fargo deliver results as earnings season gathers speed (MarketWatch)
04:11AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to hold near record highs as earnings season ramps up with JPMorgan results on tap (MarketWatch)
Apr-09-26 04:51PM	CarMax Will Add Two Board Members After Talks With Activist Investor Starboard (The Wall Street Journal)
04:15PM	CarMax Announces William Cobb and Jim Kessler to Join the Board (Business Wire)
Apr-06-26 11:16AM	Carvana Stock Doubled Last Year. Why This Analyst Isn't Bullish Anymore. (Barrons.com)
Apr-01-26 09:30AM	CARMAX CELEBRATES 22nd CONSECUTIVE YEAR AS ONE OF FORTUNE MAGAZINE'S 100 BEST COMPANIES TO WORK FOR (GlobeNewswire)
Mar-27-26 07:15AM	New CarMax CEO Barr looks to tech for better UX (Wards Auto)
Mar-26-26 04:37PM	Stock traders are wary of this market - and retail investors should be too (MarketWatch)
Mar-19-26 05:00PM	CarMax Announces Fourth Quarter Conference Call (Business Wire)
04:12PM	These charts suggest the bears aren't done with the stock market yet (MarketWatch)
Mar-18-26 11:45AM	CarMax appoints Keith Barr as CEO (Wards Auto)
Mar-13-26 08:44PM	Oracle Has More Resilience Amid AI Pressures, Says Analyst. Plus, CarMax, Rivian, and More Stocks. (Barrons.com)
Mar-12-26 06:40PM	The S&P 500 just broke a major support. Another 10% decline is likely. (MarketWatch)
Mar-11-26 04:20PM	Investor Starboard Sees CarMax Upside as Barr Takes Helm (Transport Topics)
02:30PM	Starboard Builds $350 Million Stake in CarMax, Seeks Board Seats (GuruFocus.com)
01:40PM	Starboard Takes $350 Million CarMax Stake, Seeks Board Seats (Bloomberg)
01:01PM	An Important Investor Has an Idea for CarMax: Charge Less for Used Cars (Investopedia)
11:29AM	Falling prices steer US buyers toward used electric vehicles (Reuters)
10:35AM	CarMax Issues Statement on Engagement With Starboard Value (Business Wire)
09:58AM	CarMax Stock Edges Higher as Activist Takes Stake, Says New CEO Must 'Move Quickly' (Barrons.com)
09:34AM	Activist Starboard Pushes for Change at CarMax (The Wall Street Journal)
09:17AM	CarMax Stock: Auto Business Activist Investor Takes Stake (Investor's Business Daily)
08:00AM	Starboard Delivers Letter to CarMax (Business Wire)
Mar-06-26 10:02AM	Will Carvana's Fixed Cost Leverage Drive Its EBITDA Margin? (Zacks)
09:52AM	Will Vertical Integration Strengthen Carvana's Prospects? (Zacks)
Mar-05-26 08:03AM	Carvana's Rough Start to 2026 Post Stellar 2025: How to Play the Stock (Zacks)
Mar-04-26 08:10AM	GM merging its CPO dealer sales program with CarBravo (Wards Auto)
Mar-03-26 09:40AM	Should Value Investors Buy CarMax (KMX) Stock? (Zacks)
Feb-27-26 10:36AM	CarMax Launches First-of-Its-Kind Car Shopping and Selling Experience in ChatGPT App Store (GlobeNewswire)
Feb-26-26 10:33PM	Q4 Earnings Recap: CarMax (NYSE:KMX) Tops Vehicle Retailer Stocks (StockStory)
Feb-25-26 10:10AM	Trump Trade: FedEx files suit to recoup tariff duties (TipRanks)
Feb-23-26 07:45PM	CarMax to pay $420K to resolve DOJ allegations over servicemember vehicle repossessions (Fox Business)
Feb-19-26 08:12PM	CarGurus Q4 Earnings Call Highlights (MarketBeat)
Feb-18-26 12:25PM	Why Is CarMax (KMX) Stock Soaring Today (StockStory) +8.05%
Feb-14-26 02:26PM	Carvana Drops 15% This Week: Heres The 3 Biggest Storylines (24/7 Wall St.)
Feb-13-26 08:56AM	$1 Billion Accounting Questions Cloud Carvanas 44% Sales Surge (24/7 Wall St.)
Feb-12-26 09:43AM	CarMax Taps Former Hotel CEO Keith Barr After Sales Slump (Transport Topics) -10.57%
09:00AM	Wallace Weitz Exits CarMax Inc, Impacting Portfolio by -1.58% (GuruFocus.com)
09:00AM	Eclipse backs all-EV marketplace Ever in $31M funding round (TechCrunch)
07:36AM	CarMax Names a New CEO. He's Not a Car Guy. (Barrons.com)
06:50AM	CarMax Names Keith Barr as Chief Executive Officer (Business Wire)
06:20AM	CarMax Taps Hotel Veteran to Lead Turnaround (The Wall Street Journal)
Feb-08-26 11:41PM	1 Safe-and-Steady Stock Worth Investigating and 2 We Question (StockStory)
Feb-04-26 07:30AM	CarMax Named One of TIME's America's Most Iconic Companies (GlobeNewswire)
05:44AM	CarMax, Inc. (KMX) Turns to Pricing and Marketing Actions to Revitalize Sales (Insider Monkey)
Feb-03-26 11:35PM	1 Profitable Stock to Target This Week and 2 We Turn Down (StockStory)
Jan-30-26 09:24AM	Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 (Insider Monkey)
Jan-23-26 08:56AM	Should You Hold CarMax (KMX)? (Insider Monkey)
Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%
Dec-31-25 09:51AM	Here's Why You Should Offload CarMax Stock From Your Portfolio (Zacks)
Dec-26-25 09:16AM	Can Carvana Stock Extend Its Strong 2025 Rally Into 2026? (Zacks)
Dec-25-25 12:31AM	The 5 Most Interesting Analyst Questions From CarMax's Q4 Earnings Call (StockStory)
Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)
03:34AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-20-25 10:00AM	3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500 (MarketBeat)
Dec-19-25 07:38AM	CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y (Zacks)
12:30AM	KMX Q4 Deep Dive: Margin Reset and Leadership Transition Dominate CarMax's Strategy (StockStory)
Dec-18-25 04:18PM	Stocks to Watch Thursday: Trump Media, Micron, Lululemon, Accenture (The Wall Street Journal)
04:01PM	CarMax Inc (KMX) Q3 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
12:57PM	CarMax Cutting Prices to Draw Car Shoppers Back (The Wall Street Journal)
12:36PM	CarMax Crashes into a Sales Slump as Amazon Circles the Used-Car Lot (GuruFocus.com)
11:53AM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Interim Executive ChairmanMr. Thomas Joseph Folliard

Executive VP & CFOMr. Enrique N. Mayor-Mora

Executive VP & COOMr. Charles Joseph Wilson

Executive VP and Chief Information & Technology OfficerMr. Shamim Mohammad CPA

Executive VPMs. Diane Long Cafritz J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McCreight David W.	Director	Mar 16 '26	Option Exercise	41.71	30,558	1,274,574	47,257	Mar 18 04:11 PM
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your Finviz experience